{"page_content": "Standard Operating Procedure REMEDI4All-SOPs Page: Version: 1 of 9 01 In silico drug repurposing tools and resources\n\nValid from:\n\n05.08.24\n\nCreated by Controlled by Approved by Leonie von Name Jordi Quintana Berlin, Yojana Tero Gadiya Email jordi.quintana@chemotargets.com Date 05.08.2024 07.02.2025 DD.MM.YY Signature\n\n1 Index\n\nIndex .................................................................................................................................................. 1 4.1 General ......................................................................................................................................................... 2 4.2 Information on tools and resources.............................................................................................................. 2 4.3 Procedure ...................................................................................................................................................... 3 Further applicable resources ................................................................................................................ 8 Annex ................................................................................................................................................. 8\n\n1\n\n2 Goal and Area of Application ............................................................................................................... 2\n\n3 Definitions and Abbreviations .............................................................................................................. 2\n\n4 Method............................................................................................................................................... 2\n\n5\n\n1\n\nPage: 1/9\n\nStandard Operating Procedure REMEDI4All-SOPs Page: Version: Valid from: 2 of 9 01 05.08.24 In silico drug repurposing tools and resources\n\n2 Goal and Area of Application\n\nA general goal of drug repurposing projects is to select compounds that have been approved by regulatory agencies, or that are in advanced clinical trial phases and could be prioritized to be assayed for new indications. The in silico analysis of databases and the development of predictive tools offers an opportunity to increase the efficiency of this process.\n\nThis SOP describes a potential approach to use in silico tools and databases to establish a drug repurposing workflow with the goal of identifying drugs for new indications, analyze their possible mechanisms of action (targets and pathways), and evaluate other properties like pharmacokinetics and safety.", "metadata": {"doc_id": "aff6a1cf-b101-4108-a677-ecf743525439", "content_type": "CompositeElement", "filename": "REMEDI4All_SOPs_In Silico_Repurposing.pdf"}}